From the publishers of JADPRO

DLBCL Resource Center

Advertisement

Treatment Considerations and Best Practices in the Use of Cellular Therapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Interview With Amy Goodrich, RN, BSN, MSN, CRNP-AC: Management of Aggressive High-Grade Lymphomas

Interview With Amy Goodrich, RN, BSN, MSN, CRNP-AC: The Alphabet Soup in the Pathobiology of DLBCL

Interview With Christopher D'Angelo, MD: Current Treatment Landscape for R/R DLBCL

Interview With Christopher D’Angelo, MD: Current Frontline Treatment of DLBCL Beyond R-CHOP

Interview With Gilles Salles, MD, PhD: Novel Treatments in DLBCL

Interview With Shani Irby, ANP-BC: CAR T-Cell Therapy in DLBCL

Interview With Shani Irby, ANP-BC: Relapsed DLBCL and the Role of Autologous Stem Cell Transplant

Interview With Andréa LeVoir, PharmD, BCOP: First-Line Treatment in DLBCL

Interview With Susan K. Seo, MD: COVID-19 Considerations for Patients With DLBCL

Interview With Emily Panzner, MSN, AGNP-BC: Introduction to DLBCL

Relapsed DLBCL After CAR T-Cell Therapy

Follicular Lymphoma Transformed to DLBCL

High-Grade B-Cell Lymphoma

Fast Facts #12: Long-Term Survivorship